BioVenture eLab, part of Weill Cornell Medicine Enterprise Innovation, is delighted to announce a unique opportunity for those benefiting from or considering SBIR/STTR funding to help de-risk their inventions.  
The National Cancer Institute’s Gregory L. Evans, PhD, Program Director and Team Leader for its SBIR/STTR programs, will visit the Weill Cornell Medicine campus on Tuesday, September 19. Dr. Evans will give an overview of the NIH/NCI SBIR/STTR grant program. In its most recent re-authorization of the program, Congress made certain changes to the application forms. It is important that you learn the details and understand what new information is required.

Whether you are looking to apply for an SBIR/STTR grant for the first time or have previously applied and are planning to re-submit, don’t miss this opportunity to speak directly with this prominent NCI representative.